Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CHRYSALIS BIOTHERAPEUTICS, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2017-01-30 to 2021-08-31
Current total value of award: $6954508.6
Description: DEOBLIGATE FUNDS FROM LINE ITEM.